Clinical Trial Update: Urinary Biomarkers of the Progression of Alport Kidney Disease

View source ↗

Summary

A completed clinical trial update assessing urinary biomarkers to track progression in Alport syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alport Syndrome

Snippet

Sponsor: University of Minnesota | Conditions: Alport Syndrome | Status: COMPLETED